Group 1 - The core point of the article is that Shenzhen's Peninsula Medical has received FDA 510(k) certification for its RF microneedle device, marking a significant milestone for domestic medical aesthetic brands in the international market [1] - Peninsula Medical, established in 2008, is recognized as a high-tech enterprise and a "little giant" specializing in the research, production, and sales of medical aesthetic equipment [1][2] - Shenzhen is positioning itself as an "international medical aesthetic capital," supported by various government policies aimed at fostering the development of the medical aesthetic industry [1][2] Group 2 - The Bao'an District Health Bureau has released guidelines to support the compliance and innovation of medical aesthetic enterprises, offering substantial subsidies for companies developing high-end medical aesthetic devices [2] - Notable companies in the Shenzhen medical aesthetic sector include Pumen Technology, Jisidi, and Peninsula Medical, with Pumen Technology being a representative enterprise listed on the STAR Market in 2019 [2] - Shenzhen ranks among the top cities for medical aesthetic industry performance, second only to Beijing, according to the "China Urban Medical Aesthetic Industry Development Index" [3] Group 3 - Other cities like Chengdu and Hainan are also striving to develop as "medical aesthetic capitals," but Shenzhen is seen as having a clear advantage due to its focus on internationalization and innovation in the industry [4] - Shenzhen's medical aesthetic landscape includes leading institutions like Pengai Medical, which became the first listed medical aesthetic company on NASDAQ in October 2019 [3][4]